Savara is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. It is developing MOLBREEVI, a recombinant human GM-CSF, for the treatment of autoimmune pulmonary alveolar proteinosis.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.